Tran Yvonne 4
4 · Schrodinger, Inc. · Filed May 24, 2023
Insider Transaction Report
Form 4
Tran Yvonne
EVP, CLO & CPO
Transactions
- Sale
Common Stock
2023-05-22$35.04/sh−15,000$525,632→ 12,721 total - Exercise/Conversion
Stock Option (right to buy)
2023-05-22$3.07/sh−108$332→ 0 totalExercise: $3.07Exp: 2026-05-10→ Common Stock (108 underlying) - Exercise/Conversion
Common Stock
2023-05-22$4.34/sh+14,892$64,631→ 27,721 total - Exercise/Conversion
Common Stock
2023-05-23$4.34/sh+7,960$34,546→ 20,681 total - Exercise/Conversion
Stock Option (right to buy)
2023-05-23$4.34/sh−7,960$34,546→ 3,902 totalExercise: $4.34Exp: 2028-11-29→ Common Stock (7,960 underlying) - Exercise/Conversion
Common Stock
2023-05-22$3.07/sh+108$332→ 12,829 total - Sale
Common Stock
2023-05-23$40.01/sh−7,960$318,461→ 12,721 total - Exercise/Conversion
Stock Option (right to buy)
2023-05-22$4.34/sh−14,892$64,631→ 11,862 totalExercise: $4.34Exp: 2028-11-29→ Common Stock (14,892 underlying)
Footnotes (6)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.
- [F2]Includes 7,590 unvested RSUs
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(3) of this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(4) of this Form 4.
- [F5]The option was granted on May 10, 2016 and is fully vested.
- [F6]The option was granted on November 29, 2018 and is fully vested.